CMND earnings: real EPS beat/miss history, P/E -0.14. Updated 2026-07-23.
Clearmind Medicine (CMND) Research Hub
Clearmind Medicine (CMND) trades on NASDAQ, CA in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 0.9667 USD (-8.80%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.14, market cap 0.00B. This hub links to the full technical, earnings and options research available for CMND.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 0.9667 USD (-8.80%) |
| 52-week range | 0.9199 USD – 3.48 USD |
| Trend regime | Range |
| 14-day RSI | 28.8 (Oversold) |
| Trailing P/E | -0.14 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
Available research for CMND
Covered Call on CMND: how it works, illustrative setup around the real 0.9667 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CMND: how it works, illustrative setup around the real 0.9667 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CMND: how it works, illustrative setup around the real 0.9667 USD price, max profit/loss, breakeven and when to use it. Educational.
CMND technical analysis: range, last 0.9667 USD, RSI 28.8, 52w range 0.9199 USD–3.48 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CMND in?
Clearmind Medicine (CMND) is classified under Healthcare (Biotechnology), listed on NASDAQ, CA.
Is CMND in an uptrend or downtrend?
As of 2026-09-11, CMND is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CMND's trailing P/E ratio?
CMND's trailing P/E is -0.14, with a market cap of 0.00B. See the earnings research page for full valuation detail.